Canaccord analyst Bill Maughan initiated coverage of Immunocore with a Hold rating and $67 price target.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on IMCR:
- Immunocore management to meet with Mizuho
- Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO
- Immunocore to present at upcoming investor conferences
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue